Literature DB >> 15108273

PAP: detection of ultra rare mutations depends on P* oligonucleotides: "sleeping beauties" awakened by the kiss of pyrophosphorolysis.

Qiang Liu1, Steve S Sommer.   

Abstract

Pyrophosphorolysis-activated polymerization (PAP) was initially developed to enhance the specificity of allele-specific PCR for detection of known mutations in the presence of a great excess of wild-type allele. The high specificity of PAP derives from the serial coupling of activation of a 3' blocked pyrophosphorolysis-activable oligonucleotide (P(*)) with extension of the unblocked, activated P(*). In theory, PAP can detect a copy of a single base mutation present in 3x10(11) copies of the wild-type allele. In practice, the selectivity of detection is limited by polymerase extension errors, a bypass reaction, from the unblocked oligonucleotide annealed to the opposing strand. Bi-directional PAP allele-specific amplification (Bi-PAP-A) is a derivative of PAP that uses two opposing pyrophosphorolysis activable oligonucleotides (P(*)) with one nucleotide overlap at their 3' termini. This eliminates the problematic bypass reaction. The selectivity of Bi-PAP-A was examined using lambda phage DNA as a model system. Bi-PAP-A selectively detected two copies of a rare mutated allele in the presence of at least 2x10(9) copies of the wild-type lambda phage DNA. We then applied Bi-PAP-A to direct detection of spontaneous somatic mutations in the lacI transgene in BigBlue transgenic mice at a frequency as low as 3x10(-9). A 370-fold variation in the frequency of a specific somatic mutation among different mouse samples was found, implying hyper-Poisson variance and clonal expansion of mutation occurring during early development. Bi-PAP-A is a simple, rapid, and general method capable of automation and particularly suited to detection of ultra rare mutations. We also show that P(*) oligonucleotides have the novel and unexpected property of high specificity to mismatches with the template throughout lengths of the P(*). Thus, PAP also can form the basis of microarray-based scanning or resequencing methods to detect virtually all mutations. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108273     DOI: 10.1002/humu.20036

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  Setup of a Protocol of Molecular Diagnosis of β-Thalassemia Mutations in Tunisia using Denaturing High-Performance Liquid Chromatography (DHPLC).

Authors:  Chaima Abdelhafidh Sahli; Ikbel Ben Salem; Latifa Jouini; Naouel Laouini; Rym Dabboubi; Sondes Hadj Fredj; Hajer Siala; Rym Othmeni; Boutheina Dakhlaoui; Slaheddine Fattoum; Amina Bibi; Taieb Messaoud
Journal:  J Clin Lab Anal       Date:  2016-04-18       Impact factor: 2.352

2.  Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.

Authors:  Jessica M E van den Oever; Sahila Balkassmi; Tim Segboer; E Joanne Verweij; Pieter A van der Velden; Dick Oepkes; Egbert Bakker; Elles M J Boon
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

3.  Real-time bidirectional pyrophosphorolysis-activated polymerization for quantitative detection of somatic mutations.

Authors:  Najie Song; Xueting Zhong; Qingge Li
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

4.  Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications.

Authors:  Barbara Arbeithuber; Kateryna D Makova; Irene Tiemann-Boege
Journal:  DNA Res       Date:  2016-07-31       Impact factor: 4.458

5.  Mass-spectrometry analysis of modifications at DNA termini induced by DNA polymerases.

Authors:  Igor P Smirnov; Natalia A Kolganova; Vadim A Vasiliskov; Alexander V Chudinov; Edward N Timofeev
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

6.  Mutation detection by real-time PCR: a simple, robust and highly selective method.

Authors:  John Morlan; Joffre Baker; Dominick Sinicropi
Journal:  PLoS One       Date:  2009-02-25       Impact factor: 3.240

7.  Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancer.

Authors:  Zhenbin Chen; Jinong Feng; Carolyn H Buzin; Qiang Liu; Lawrence Weiss; Kemp Kernstine; George Somlo; Steve S Sommer
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

8.  PAP-LMPCR for improved, allele-specific footprinting and automated chromatin fine structure analysis.

Authors:  R Ingram; C Gao; J Lebon; Q Liu; R J Mayoral; S S Sommer; M Hoogenkamp; A D Riggs; C Bonifer
Journal:  Nucleic Acids Res       Date:  2008-01-21       Impact factor: 16.971

9.  Modified Proofreading PCR for Detection of Point Mutations, Insertions and Deletions Using a ddNTP-Blocked Primer.

Authors:  Weiming Hao; Lujuan Fan; Qianqian Chen; Xiaoxiang Chen; Sichao Zhang; Ke Lan; Jian Lu; Chiyu Zhang
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.